{"podcast":{"title":"Diabetes Insights - Breakthroughs and Innovators","slug":"diabetes-insights-breakthroughs-and-innovators-7109701","podcast_index_feed_id":7109701,"rss_url":"https://diabetes-insights.podigee.io/feed/mp3","website_url":"https://www.easd.org/","image_url":"https://images.podigee-cdn.net/0x,sD408c5FPq2zhlfDJcAkTWInzitsc0zqUqRLVfdBTdxE=/https://main.podigee-cdn.net/uploads/u69742/58c554e5-7dfd-4038-8798-07007c3176cf.jpg","author":"EASD - European Association for the Study of Diabetes","episode_count":74,"summary":"EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at an EASD Annual Meeting. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/). New episode released every Friday.","last_synced_at":"2026-09-18T02:19:18.006264+00:00","page_url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701"},"episode":{"title":"Towards arresting type 1 diabetes: Breaking results of the MELD-ATG & Ver-A-T1D trials","slug":"towards-arresting-type-1-diabetes-breaking-results-of-the-meld-atg-ver-a-t1d-trials","published_at":"2026-03-13T07:00:00+00:00","page_url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701/towards-arresting-type-1-diabetes-breaking-results-of-the-meld-atg-ver-a-t1d-trials","show_page_url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701","url":"https://diabetes-insights.podigee.io/55-towards-arresting-type-1-diabetes-breaking-results-of-the-meld-atg-ver-a-t1d-trials","audio_url":"https://audio.podigee-cdn.net/2395839-m-cb2e4641e8f77d905892d0a7bb34aba5.mp3?source=feed","summary":"In this episode, Prof. Chantal Mathieu and Prof. Francesco Dotta discuss two major European clinical trials presented at the EASD Annual Meeting: MELD-ATG and VERA-T1D. Both studies were conducted through the INNODIA consortium, a large European collaboration aimed at identifying biomarkers and testing new disease-modifying therapies for type 1 diabetes. The VERA-T1D trial investigated verapamil, a long-established cardiovascular drug, for its potential to preserve beta cell function after diagnosis. While the study narrowly missed its primary endpoint, the results provide important insights into disease heterogeneity and future combination therapies. The MELD-ATG trial used an innovative adaptive trial design to identify an effective low dose of anti-thymocyte globulin (ATG), showing that a single low-dose infusion may help delay beta-cell decline in newly diagnosed patients. Together, these studies highlight the rapid progress being made in type 1 diabetes research and the growing move toward precision medicine approaches.","meta_description":"In this episode, Prof. Chantal Mathieu and Prof. Francesco Dotta discuss two major European clinical trials presented at the EASD Annual Meeting: MELD-ATG…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1035,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/diabetes-insights-breakthroughs-and-innovators-7109701/episodes/towards-arresting-type-1-diabetes-breaking-results-of-the-meld-atg-ver-a-t1d-trials/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701/towards-arresting-type-1-diabetes-breaking-results-of-the-meld-atg-ver-a-t1d-trials.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}